Literature DB >> 22699275

Mechanisms of lipoprotein(a) pathogenicity: prothrombotic, proatherosclerotic, or both?

J David Spence, Marlys Koschinsky.   

Abstract

Mesh：

Substances：

Year:  2012        PMID： 22699275     DOI： 10.1161/ATVBAHA.112.251306

Source DB:  PubMed          Journal:  Arterioscler Thromb Vasc Biol        ISSN： 1079-5642            Impact factor:   8.311


× No keyword cloud information.
  30 in total

Review 1.  Lipoprotein apheresis for the treatment of elevated circulating levels of lipoprotein(a): a critical literature review.

Authors:  Massimo Franchini; Enrico Capuzzo; Giancarlo M Liumbruno
Journal:  Blood Transfus       Date:  2015-12-22       Impact factor: 3.443

2.  Lp(a) (Lipoprotein(a)) Levels Predict Progression of Carotid Atherosclerosis in Subjects With Atherosclerotic Cardiovascular Disease on Intensive Lipid Therapy: An Analysis of the AIM-HIGH (Atherothrombosis Intervention in Metabolic Syndrome With Low HDL/High Triglycerides: Impact on Global Health Outcomes) Carotid Magnetic Resonance Imaging Substudy-Brief Report.

Authors:  Daniel S Hippe; Binh An P Phan; Jie Sun; Daniel A Isquith; Kevin D O'Brien; John R Crouse; Todd Anderson; John Huston; Santica M Marcovina; Thomas S Hatsukami; Chun Yuan; Xue-Qiao Zhao
Journal:  Arterioscler Thromb Vasc Biol       Date:  2018-01-04       Impact factor: 8.311

Review 3.  Lipoprotein (a) as a cause of cardiovascular disease: insights from epidemiology, genetics, and biology.

Authors:  Børge G Nordestgaard; Anne Langsted
Journal:  J Lipid Res       Date:  2016-09-27       Impact factor: 5.922

4.  Carotid artery stiffness evaluated early by wave intensity in normal left ventricular function in post-radiotherapy patients with nasopharyngeal carcinoma.

Authors:  Zhuo Zhang; Runlan Luo; Bijun Tan; Jing Qian; Yanfang Duan; Nan Wang; Guangsen Li
Journal:  J Med Ultrason (2001)       Date:  2017-09-05       Impact factor: 1.314

Review 5.  New Era of Lipid-Lowering Drugs.

Authors:  Philip J Barter; Kerry-Anne Rye
Journal:  Pharmacol Rev       Date:  2016-04       Impact factor: 25.468

6.  Oxidation-specific biomarkers and risk of peripheral artery disease.

Authors:  Monica L Bertoia; Jennifer K Pai; Jun-Hee Lee; Adam Taleb; Michel M Joosten; Murray A Mittleman; Xiaohong Yang; Joseph L Witztum; Eric B Rimm; Sotirios Tsimikas; Kenneth J Mukamal
Journal:  J Am Coll Cardiol       Date:  2013-03-26       Impact factor: 24.094

Review 7.  Epidemiological association between migraine and lipoprotein(a): a systematic review.

Authors:  Camilla Mattiuzzi; Gianfranco Cervellin; Giuseppe Lippi
Journal:  J Thromb Thrombolysis       Date:  2015-01       Impact factor: 2.300

8.  Elevated Lipoprotein (a) and Risk of Poor Functional Outcome in Chinese Patients with Ischemic Stroke and Type 2 Diabetes.

Authors:  Haoliang Wang; Jun Zhao; Yongkun Gui; Haiqing Yan; Zhixin Yan; Ping Zhang; Li Liu; Li Chang; Jianlong Zhang
Journal:  Neurotox Res       Date:  2017-12-20       Impact factor: 3.911

9.  Distinct metabolism of apolipoproteins (a) and B-100 within plasma lipoprotein(a).

Authors:  Margaret R Diffenderfer; Stefania Lamon-Fava; Santica M Marcovina; P Hugh R Barrett; Julian Lel; Gregory G Dolnikowski; Lars Berglund; Ernst J Schaefer
Journal:  Metabolism       Date:  2015-11-06       Impact factor: 8.694

Review 10.  Lipoprotein (a): truly a direct prothrombotic factor in cardiovascular disease?

Authors:  Michael B Boffa; Marlys L Koschinsky
Journal:  J Lipid Res       Date:  2015-12-08       Impact factor: 5.922
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.